Historical record - last NADAC effective date: 5/19/2021
Product Information
SOLIFENACIN 5 MG TABLET is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.2593 per EA under NDC 27241003709. Its NADAC has been published 93 times since Aug 21, 2019.
FDA first approved this application on May 20, 2019.
The High Outlier badge above means this manufacturer's average price in the solifenacin succinate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241003709
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
5/19/2021
Active Ingredients
SOLIFENACIN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA205483FDA Approved
5/20/2019
On Market Since
5/20/2019
Pharmacological Classes
Price Statistics
The NADAC for SOLIFENACIN 5 MG TABLET has been published 93 times since Aug 21, 2019, and over the history we have for it it has declined 45.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2593 per EA |
|---|---|
| All-time high | $0.4775 (Sep 11, 2019) |
| All-time low | $0.2322 (Apr 21, 2021) |
| Median price | $0.3046 |
| Average price | $0.2989 |
| Largest weekly change | +31.3% (Oct 21, 2020) |
| Weeks tracked | 93 |
| Tracking since | Aug 21, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-45.7%
Last surveyed May 26, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ajanta Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
solifenacin succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Muscarinic Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SOLIFENACIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SOLIFENACIN 5 MG TABLET, manufactured by Ajanta Pharma USA Inc., is $0.2593 per EA (NDC 27241003709), effective May 26, 2021.
How has the price of SOLIFENACIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for SOLIFENACIN 5 MG TABLET has declined 45.7%. It has been tracked across 93 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for SOLIFENACIN 5 MG TABLET?
Since Aug 21, 2019, the NADAC for SOLIFENACIN 5 MG TABLET has ranged from a low of $0.2322 (Apr 21, 2021) to a high of $0.4775 (Sep 11, 2019), with a median of $0.3046 per EA.
Are there cheaper alternatives to SOLIFENACIN 5 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SOLIFENACIN 5 MG TABLET, is $0.1413 per EA — about 45% below SOLIFENACIN 5 MG TABLET.
Who manufactures SOLIFENACIN 5 MG TABLET?
SOLIFENACIN 5 MG TABLET (NDC 27241003709) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.